CHI & Bio-IT World Announce Free Energy Approach to Structure-Based Drug Design Session

CHI and Bio-IT World's "Structure-Based Design" Conference to be held on June 8-10, 2011 in Cambridge, MA, will feature a new session: Free Energy Approach to Structure-Based Drug Design
 
April 18, 2011 - PRLog -- Cambridge Healthtech Institute and Bio-IT World is pleased to announce a new session just added to its 11th Annual Structure-Based Drug Design (SBDD) conference.  The session is titled Free Energy Approach to Structure-Based Drug Design.  The SBDD conference will be held on June 8-10, 2011 at the Royal Sonesta Hotel Boston in Cambridge, Massachusetts.  This meeting serves as the annual forum for the structure-based drug design community, providing insights on the latest development in computational technology for drug discovery, and puts structure-based molecular approaches into the perspective of targeted therapeutics.

The Free Energy Approach to Structure-Based Drug Design Session is scheduled on Friday, June 10 from 9:05 a.m. – 12:20 p.m. The following presentations are scheduled during this time:

The Binding Energy Distribution Analysis Method (BEDAM) for Structure-Based Drug Design: Theory and Applications
Ronald M. Levy, Ph.D., Board of Governors, Professor of Chemistry & Chemical Biology, Rutgers University

Fragment-Based Screening by Free Energy Simulations
Jonathan Essex, Ph.D., Head, Computational Systems Chemistry; Chairman, Institute for

Complex Systems Simulation (ICSS), School of Chemistry, University of Southampton
A New Computational Method for Predicting Binding Free Energies of Protein-Ligand Interactions
Christopher Langmead, Ph.D., Associate Professor of Computer Science, Carnegie Mellon University

Millisecond-Long Molecular Dynamics Simulations of Proteins on a Special-Purpose Machine
David E. Shaw, Ph.D., Chief Scientist, D. E. Shaw Research and Senior Research Fellow, Center for Computational Biology and Bioinformatics, Columbia University

Millisecond-Long Molecular Dynamics Simulations of Proteins on a Special-Purpose Machine
David E. Shaw, Ph.D., Chief Scientist, D. E. Shaw Research and Senior Research Fellow, Center for Computational Biology and Bioinformatics, Columbia University

Molecular Field Based Virtual Screening and Molecular Design
Jascha Blobel, Ph.D., Product Manager, Sales & Product Development, Intelligent Pharma

View full details and register at: http://www.healthtech.com/sbd

Those that register before April 29 will receive the advanced registration discount.

Writers and editors are invited to attend.  To request a press pass, contact Tracey Fielding at tfielding@healthtech.com.

About Cambridge Healthtech Institute (http://www.chicorporate.com)
Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

About Bio-IT World: (http://www.bio-itworld.com)
Part of the Cambridge Healthtech Institute Media Group (http://www.chimediagroup.com), Bio-IT World magazine is a bimonthly publication that life science and IT/informatics professionals continuously reference to find information, news, and commentary on indispensable technologies and business strategies.  Bio-IT World provides outstanding coverage of cutting-edge trends and technologies that impact the management and analysis of life sciences data, including next-generation sequencing, drug discovery, predictive and systems biology, informatics tools, clinical trials, and personalized medicine. Cambridge Healthtech Media Group also hosts daily news and opinion at http://www.bio-itworld.com, a variety of e-newsletters, and a rich compendium of webinars and web symposia.  Cambridge Healthtech Media Group is based in Needham, Mass.

Contact:
James Prudhomme
Cambridge Healthtech Institute
781-972-5400
jprudhomme@healthtech.com
http://www.healthtech.com/sbd
End
Cambridge Healthtech Institute News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share